Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein
Open Access
- 1 January 2011
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 17 (2) , 151-63
Abstract
To investigate the mechanisms involved in a possible modulator role of interleukin (IL)-6 signalling on CYR61-CTGF-NOV (CCN) 2/connective tissue growth factor (CTGF) expression in hepatocytes (PC) and to look for a relation between serum concentrations of these two parameters in patients with acute inflammation. Expression of CCN2/CTGF, p-STAT3, p-Smad3/1 and p-Smad2 was examined in primary freshly isolated rat or cryo-preserved human PC exposed to various stimuli by Western blotting, electrophoretic mobility shift assay (EMSA), reporter-gene-assays and reverse-transcriptase polymerase chain reaction. IL-6 strongly down-regulated CCN2/CTGF protein and mRNA expression in PC, enhanceable by extracellular presence of the soluble IL-6 receptor gp80, and supported by an inverse relation between IL-6 and CCN2/CTGF concentrations in patients' sera. The inhibition of TGFβ1 driven CCN2/CTGF expression by IL-6 did not involve a modulation of Smad2 (and Smad1/3) signalling. However, the STAT3 SH2 domain binding peptide, a selective inhibitor of STAT3 DNA binding activity, counteracted the inhibitory effect of IL-6 on CCN2/CTGF expression much more pronounced than pyrrolidine-dithiocarbamate, an inhibitor primarily of STAT3 phosphorylation. An EMSA confirmed STAT3 binding to the proposed proximal STAT binding site in the CCN2/CTGF promoter. CCN2/CTGF is identified as a hepatocellular negative acute phase protein which is down-regulated by IL-6 via the STAT3 pathway through interaction on the DNA binding level.Keywords
This publication has 41 references indexed in Scilit:
- Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor β actions in hepatocytes—But without modulating bone morphogenetic protein 7 signaling†Hepatology, 2009
- Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancerJournal of Leukocyte Biology, 2006
- Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in ratsThe Journal of Gene Medicine, 2006
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002
- Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitroGastroenterology, 2002
- Identification of human ccn2 (connective tissue growth factor) promoter polymorphismsMolecular Pathology, 2001
- V. TGF-β signaling pathwaysAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5Virology, 1988
- Role of the Liver in InflammationNature New Biology, 1971